OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
Provided By GlobeNewswire
Last update: Mar 12, 2025
WALTHAM, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced results for the fourth quarter and full year ended December 31, 2024.
Read more at globenewswire.com
